RESUMEN
PURPOSE OF REVIEW: The aim of the review is to describe the different clinical pictures of anaphylaxis (phenotypes), in relation to the underlying mechanisms and potential biomarkers, to describe anaphylaxis endotypes. This may aid in achieving a better understanding, management and outcomes of such severe reactions. RECENT FINDINGS: Different anaphylaxis phenotypes have been outlined, ranging from the classical type-I-like to those suggestive of cytokine-storm-like or complement-mediated reactions. Underlying mechanisms differ and biomarkers of cells and systems involved are being identified (tryptase, IL-6, bradykinin etc.) SUMMARY: Identifying specific phenotypes/endotypes will allow the application of precision medicine in patients with anaphylaxis, providing insights to the most appropriate approach in each case.
Asunto(s)
Anafilaxia/inmunología , Biomarcadores/metabolismo , Activación de Complemento/inmunología , Citocinas/inmunología , Fenotipo , Anafilaxia/metabolismo , Basófilos/inmunología , Bradiquinina/inmunología , Bradiquinina/metabolismo , Carboxipeptidasas A/inmunología , Carboxipeptidasas A/metabolismo , Quimasas/inmunología , Quimasas/metabolismo , Citocinas/metabolismo , Histamina/inmunología , Histamina/metabolismo , Humanos , Inmunoglobulina E/inmunología , Inmunoglobulina G/inmunología , Interleucina-6/inmunología , Interleucina-6/metabolismo , Mastocitos/inmunología , Factor de Activación Plaquetaria/inmunología , Factor de Activación Plaquetaria/metabolismo , Medicina de Precisión , Triptasas/inmunología , Triptasas/metabolismoRESUMEN
Infection with the helminth parasite Strongyloides stercoralis (Ss) is commonly clinically asymptomatic that is often accompanied by peripheral eosinophilia. Granulocytes are activated during helminth infection and can act as immune effector cells. Plasma levels of eosinophil and neutrophil granular proteins convey an indirect measure of granulocyte degranulation and are prominently augmented in numerous helminth-infected patients. In this study, we sought to examine the levels of eosinophil, neutrophil, and mast cell activation-associated granule proteins in asymptomatic Ss infection and to understand their kinetics following anthelmintic therapy. To this end, we measured the plasma levels of eosinophil cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase, eosinophil major basic protein, neutrophil elastase, myeloperoxidase, neutrophil proteinase-3, mast cell tryptase, leukotriene C4, and mast cell carboxypeptidase-A3 in individuals with asymptomatic Ss infection or without Ss infection [uninfected (UN)]. We also estimated the levels of all of these analytes in infected individuals following definitive treatment of Ss infection. We demonstrated that those infected individuals have significantly enhanced plasma levels of eosinophil cationic protein, eosinophil-derived neurotoxin, eosinophil peroxidase, eosinophil major basic protein, elastase, myeloperoxidase, mast cell tryptase, leukotriene C4, and carboxypeptidase-A3 compared to UN individuals. Following the treatment of Ss infection, each of these granulocyte-associated proteins drops significantly. Our data suggest that eosinophil, neutrophil, and mast cell activation may play a role in the response to Ss infection.
Asunto(s)
Proteínas en los Gránulos del Eosinófilo/sangre , Eosinófilos/inmunología , Mastocitos/inmunología , Neutrófilos/inmunología , Strongyloides stercoralis/inmunología , Estrongiloidiasis/sangre , Adulto , Animales , Antiprotozoarios/uso terapéutico , Infecciones Asintomáticas/terapia , Carboxipeptidasas A/sangre , Carboxipeptidasas A/inmunología , Carboxipeptidasas A/metabolismo , Proteínas en los Gránulos del Eosinófilo/inmunología , Proteínas en los Gránulos del Eosinófilo/metabolismo , Eosinófilos/metabolismo , Femenino , Interacciones Huésped-Parásitos/inmunología , Humanos , Elastasa de Leucocito/sangre , Elastasa de Leucocito/inmunología , Elastasa de Leucocito/metabolismo , Leucotrieno C4/sangre , Leucotrieno C4/inmunología , Leucotrieno C4/metabolismo , Masculino , Mastocitos/metabolismo , Persona de Mediana Edad , Neutrófilos/metabolismo , Peroxidasa/sangre , Peroxidasa/inmunología , Peroxidasa/metabolismo , Vesículas Secretoras/inmunología , Vesículas Secretoras/metabolismo , Strongyloides stercoralis/aislamiento & purificación , Estrongiloidiasis/tratamiento farmacológico , Estrongiloidiasis/inmunología , Estrongiloidiasis/parasitología , Resultado del Tratamiento , Triptasas/sangre , Triptasas/inmunología , Triptasas/metabolismo , Adulto JovenRESUMEN
Transmission-blocking vaccines (TBV) interrupt malaria parasite transmission and hence form an important component for malaria eradication. Mosquito midgut exopeptidases such as aminopeptidase N & carboxypeptidase B have demonstrated TBV potential. In the present study, we cloned and characterized carboxypeptidase A (CPA) from the midgut of an important malarial vector, Anopheles stephensi. ClustalW amino acid alignment and in silico 3-dimensional structure analysis of CPA predicted the presence of active sites involved in zinc and substrate binding that are conserved among all the known mosquito species. Real-time PCR analysis demonstrated that CPA is predominantly expressed in the midgut throughout the mosquito life cycle and that this gene is significantly elevated in P. berghei-infected mosquitoes compared to uninfected blood-fed controls. The high midgut CPA activity correlated with the prominent mRNA levels observed. Peptide-based anti-CPA antibodies were raised that cross-reacted specifically to â¼48kDa and â¼37kDa bands, which correspond to zymogen and active forms of CPA. Further, the addition of CPA-directed antibodies to P. berghei-containing blood meal significantly reduced the mosquito infection rate in the test group compared to control and blocked the parasite development in the midgut. These results support further development of A. stephensi CPA as a candidate TBV.
Asunto(s)
Anopheles/enzimología , Carboxipeptidasas A/genética , Clonación Molecular , Tracto Gastrointestinal/enzimología , Insectos Vectores/enzimología , Vacunas contra la Malaria , Plasmodium berghei , Animales , Anopheles/anatomía & histología , Anopheles/genética , Anopheles/parasitología , Carboxipeptidasas A/química , Carboxipeptidasas A/inmunología , Carboxipeptidasas A/metabolismo , Femenino , Tracto Gastrointestinal/inmunología , Tracto Gastrointestinal/parasitología , Regulación Enzimológica de la Expresión Génica , Humanos , Insectos Vectores/anatomía & histología , Insectos Vectores/parasitología , Malaria/parasitología , Malaria/prevención & control , Malaria/transmisión , Masculino , Plasmodium berghei/crecimiento & desarrollo , Reacción en Cadena en Tiempo Real de la PolimerasaRESUMEN
BACKGROUND: Airway hyperresponsiveness (AHR) to inhaled mannitol is associated with indirect markers of mast cell activation and eosinophilic airway inflammation. It is unknown how AHR to mannitol relates to mast cell phenotype, mast cell function and measures of eosinophilic inflammation in airway tissue. We compared the number and phenotype of mast cells, mRNA expression of mast cell-associated genes and number of eosinophils in airway tissue of subjects with asthma and healthy controls in relation to AHR to mannitol. METHODS: Airway hyperresponsiveness to inhaled mannitol was measured in 23 non-smoking, corticosteroid-free asthmatic individuals and 10 healthy controls. Mast cells and eosinophils were identified in mucosal biopsies from all participants. Mast cells were divided into phenotypes based on the presence of chymase. mRNA expression of mast cell-associated genes was measured by real-time PCR. RESULTS: The proportion of submucosal MCTC was higher in asthmatic individuals with AHR to mannitol compared with asthmatic individuals without AHR (median: 40.3% vs. 18.7%, P = 0.03). Increased submucosal MCTC numbers were associated with increased levels of mRNA for thymic stromal lymphopoietin (TSLP) and CPA3 in asthmatics. Reactivity to mannitol correlated significantly with eosinophils in submucosa (r(s): 0.56, P = 0.01). CONCLUSION: Airway hyperresponsiveness to inhaled mannitol is associated with an altered submucosal mast cell profile in asthmatic individuals. This mast cell profile is associated with increased levels of TSLP and CPA3. The degree of AHR to mannitol is correlated with the degree of eosinophilic inflammation in the airway submucosa.
Asunto(s)
Asma/inmunología , Hiperreactividad Bronquial/inmunología , Eosinófilos/inmunología , Inflamación/inmunología , Mastocitos/inmunología , Adulto , Carboxipeptidasas A/biosíntesis , Carboxipeptidasas A/inmunología , Quimasas/inmunología , Estudios Transversales , Citocinas/biosíntesis , Citocinas/inmunología , Femenino , Humanos , Inmunohistoquímica , Masculino , Manitol/inmunología , Manitol/farmacología , Reacción en Cadena en Tiempo Real de la Polimerasa , Pruebas de Función Respiratoria/métodos , Mucosa Respiratoria/inmunología , Transcriptoma , Adulto Joven , Linfopoyetina del Estroma TímicoRESUMEN
Mast cell (MC) granules contain large amounts of proteases of the chymase, tryptase and carboxypeptidase A (MC-CPA) type that are stored in complex with serglycin,a proteoglycan with heparin side chains. Hence, serglycinprotease complexes are released upon MC degranulation and may influence local inflammation. Here we explored the possibility that a serglycin-protease axis may regulate levels of IL-13, a cytokine involved in allergic asthma. Indeed, we found that wild-type MCs efficiently degraded exogenous or endogenously produced IL-13 upon degranulation,whereas serglycin −/− MCs completely lacked this ability.Moreover, MC-mediated IL-13 degradation was blocked both by a serine protease inhibitor and by a heparin antagonist,which suggests that IL-13 degradation is catalyzed by serglycin-dependent serine proteases and that optimal IL-13 degradation is dependent on both the serglycin and the protease component of the serglycin-protease complex.Moreover, IL-13 degradation was abrogated in MC-CPA −/−MC cultures, but was normal in cultures of MCs with an inactivating mutation of MC-CPA, which suggests that the IL-13-degrading serine proteases rely on MC-CPA protein.Together, our data implicate a serglycin-serine protease axis in the regulation of extracellular levels of IL-13. Reduction of IL-13 levels through this mechanism possibly can provide a protective function in the context of allergic inflammation.
Asunto(s)
Interleucina-13/metabolismo , Mastocitos/fisiología , Proteoglicanos/metabolismo , Serina Proteasas/metabolismo , Proteínas de Transporte Vesicular/metabolismo , Animales , Carboxipeptidasas A/genética , Carboxipeptidasas A/inmunología , Carboxipeptidasas A/metabolismo , Degranulación de la Célula , Células Cultivadas , Eliminación de Gen , Heparina/inmunología , Heparina/metabolismo , Antagonistas de Heparina/farmacología , Hipersensibilidad/inmunología , Hipersensibilidad/metabolismo , Interleucina-13/inmunología , Ratones , Peritoneo/citología , Proteoglicanos/genética , Proteoglicanos/inmunología , Proteolisis , Serina Proteasas/inmunología , Inhibidores de Serina Proteinasa/farmacología , Proteínas de Transporte Vesicular/genética , Proteínas de Transporte Vesicular/inmunologíaRESUMEN
A second-degree epidermal scald burn in mice elicits an inflammatory response mediated by natural IgM directed to nonmuscle myosin with complement activation that results in ulceration and scarring. We find that such burn injury is associated with early mast cell (MC) degranulation and is absent in WBB6F1-Kit(W)/Kit(Wv) mice, which lack MCs in a context of other defects due to a mutation of the Kit receptor. To address further an MC role, we used transgenic strains with normal lineage development and a deficiency in a specific secretory granule component. Mouse strains lacking the MC-restricted chymase, mouse MC protease (mMCP)-4, or elastase, mMCP-5, show decreased injury after a second-degree scald burn, whereas mice lacking the MC-restricted tryptases, mMCP-6 and mMCP-7, or MC-specific carboxypeptidase A3 activity are not protected. Histologic sections showed some disruption of the epidermis at the scald site in the protected strains suggesting the possibility of topical reconstitution of full injury. Topical application of recombinant mMCP-5 or human neutrophil elastase to the scalded area increases epidermal injury with subsequent ulceration and scarring, both clinically and morphologically, in mMCP-5-deficient mice. Restoration of injury requires that topical administration of recombinant mMCP-5 occurs within the first hour postburn. Importantly, topical application of human MC chymase restores burn injury to scalded mMCP-4-deficient mice but not to mMCP-5-deficient mice revealing nonredundant actions for these two MC proteases in a model of innate inflammatory injury with remodeling.
Asunto(s)
Quemaduras/inmunología , Quimasas/inmunología , Cicatriz/inmunología , Epidermis/inmunología , Mastocitos/inmunología , Modelos Inmunológicos , Serina Endopeptidasas/inmunología , Animales , Quemaduras/enzimología , Quemaduras/genética , Quemaduras/patología , Carboxipeptidasas A/genética , Carboxipeptidasas A/inmunología , Carboxipeptidasas A/metabolismo , Degranulación de la Célula/genética , Degranulación de la Célula/inmunología , Quimasas/genética , Quimasas/metabolismo , Quimasas/farmacología , Cicatriz/enzimología , Cicatriz/genética , Cicatriz/patología , Epidermis/enzimología , Epidermis/patología , Humanos , Inmunoglobulina M/genética , Inmunoglobulina M/inmunología , Inmunoglobulina M/metabolismo , Inflamación , Elastasa de Leucocito/genética , Elastasa de Leucocito/inmunología , Elastasa de Leucocito/metabolismo , Elastasa de Leucocito/farmacología , Mastocitos/enzimología , Mastocitos/patología , Ratones , Ratones Endogámicos BALB C , Ratones Mutantes , Miosinas/genética , Miosinas/inmunología , Miosinas/metabolismo , Proteínas Proto-Oncogénicas c-kit , Serina Endopeptidasas/genética , Serina Endopeptidasas/metabolismo , Serina Endopeptidasas/farmacología , Triptasas/genética , Triptasas/inmunología , Triptasas/metabolismo , Triptasas/farmacologíaRESUMEN
UNLABELLED: This study aims to determine the efficacy of Salmonella enterica serovar Typhimurium STM-1 bearing MCP-3 gene as a delivery vehicle for the HIV gag gene (in particular p24 gene) and HIV env gene. The STM1 delivery HIV-p24 vaccination was carried out in the form of a recombinant or a DNA vaccine whereas only a DNA vaccine was used for HIV env . Naked DNA vaccination was also tested and immune responses were evaluated following immunisation in mouse model. RESULTS: vaccination cellular immune responses induced by recombinant p24 STM1 (STM1/pHly-p24) were greater than those elicited by the p24 DNA vaccine in STM1 (STM1/VR-p24), (but statistically not significant) than those induced by oral vaccination. However, IgA responses induced by oral vaccination with either a recombinant or DNA vaccine of p24 in STM1 are higher than those induced by IP vaccination. In addition, the numbers of cells secreting IL4 are reduced after oral vaccination with STM1/VR-p24/MCP3. However, for the HIV p24 antigen, STM1/MCP3 preferentially induces IFNgamma-secreting splenocytes. CONCLUSIONS: This result confirms other studies that Salmonella was able to deliver HIV antigens to the immune system and induced specific immune responses to the HIV antigen and for the HIV p24 antigen, STM1/MCP3 induces secretion of IFNgamma.
Asunto(s)
Vacunas contra el SIDA/inmunología , Carboxipeptidasas A/inmunología , Expresión Génica , Vectores Genéticos/inmunología , Proteína p24 del Núcleo del VIH/inmunología , Infecciones por VIH/inmunología , Salmonella typhimurium/inmunología , Productos del Gen env del Virus de la Inmunodeficiencia Humana/inmunología , Vacunas contra el SIDA/administración & dosificación , Vacunas contra el SIDA/genética , Animales , Anticuerpos Antivirales/inmunología , Carboxipeptidasas A/genética , Femenino , Técnicas de Transferencia de Gen , Vectores Genéticos/genética , Proteína p24 del Núcleo del VIH/administración & dosificación , Proteína p24 del Núcleo del VIH/genética , Humanos , Ratones , Ratones Endogámicos BALB C , Salmonella typhimurium/genética , Vacunación , Productos del Gen env del Virus de la Inmunodeficiencia Humana/administración & dosificación , Productos del Gen env del Virus de la Inmunodeficiencia Humana/genéticaRESUMEN
Acyclic nucleoside phosphonates are potent antiviral agents effective against replication of DNA viruses and retroviruses including human immunodeficiency virus (HIV). In addition to their antimetabolic mode of antiviral action, acyclic nucleoside phosphonates also possess immunomodulatory properties. We have shown recently that a number of them stimulate secretion of cytokines including chemokines RANTES/CCL5 ("regulated upon activation, normal T cell expressed and secreted") and MIP-1 alpha/CCL3 (macrophage inflammatory protein-1 alpha) that may inhibit entry of HIV in cells. In present experiments we analyzed effects of acyclic nucleoside phosphonates on gene expression of other members of the beta family of chemokines, monocyte chemotactic proteins (MCPs), which have also been implicated in the control of HIV infection. The following compounds differing at the type of heterocyclic base, i.e. adenine (A), or 2,6-diaminopurine (DAP), at the 6-amino group of the base, and at the N ( 9 )-side chain represented by 9-[2-(phosphonomethoxy)ethyl] (PME) and 9-[2-(phosphonomethoxy)propyl] (PMP) moieties were included in the study: (1) (R)-PMPA, ie. tenofovir, (2) N ( 6 )-cyclopropyl-(R)-PMPDAP, (3) N ( 6 )-cyclopentyl-(R)-PMPDAP, (4) N ( 6 )-dimethylaminoethyl-(R)-PMPDAP, (5) N ( 6 )-cyclopentyl-PMEDAP, (6) N ( 6 )-isobutyl-PMEDAP, (7) N ( 6 ) -cyclohexylmetyl-PMEDAP, and (8) N ( 6 ) -cyclooctyl-PMEDAP. These compounds are able to activate production of MCP-1 and MCP-3, and none of them influences gene expression of MCP-2, and MCP-5. Enhancement of monocyte chemotactic protein expression was found to be mediated by transcriptional factor nuclear factor-kappaB (NF-kappaB).
Asunto(s)
Fármacos Anti-VIH/farmacología , Carboxipeptidasas A/biosíntesis , Quimiocina CCL2/biosíntesis , Infecciones por VIH/metabolismo , VIH/metabolismo , Nucleósidos/farmacología , Animales , Carboxipeptidasas A/inmunología , Células Cultivadas , Quimiocina CCL2/inmunología , Femenino , VIH/inmunología , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/inmunología , Humanos , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/metabolismo , Ratones , Replicación Viral/efectos de los fármacos , Replicación Viral/inmunologíaRESUMEN
BACKGROUND: Raising selectivity to tumor cells is a major challenge for most chemotherapy drugs. One of approaches to realizing this goal is antibody-directed enzyme prodrug therapy (ADEPT). This study was done to investigate the curative effect of a new ADEPT system for the treatment of prostate cancer. METHODS: Methotrexate (MTX) prodrugs were synthesized and anti-seminoprotein (SM) single-chain antibody/human carboxypeptidase-A fusion protein (scFv/hCPA) was prepared. Therapeutic effects of this ADEPT system were evaluated. RESULTS: The synthesis of prodrugs was successful and the prodrugs were confirmed no cytotoxicity, but hydrolysis with tumor-targeted scFv/hCPA fusion protein gave 1,000-fold higher cytotoxicity than MTX-alpha-Phe only. Cell cycle assays showed that tumor cells were arrested in the S phase after ADEPT treatment; furthermore, tumors were inhibited significantly in scFv/hCPA and MTX-alpha-Phe treated mice. CONCLUSIONS: Our results suggest that targeted activation cytotoxicity against established prostate cancer by scFv/hCPA mediated ADEPT is tumor-specific and has no systemic toxicity in vitro and in vivo.
Asunto(s)
Carboxipeptidasas A/uso terapéutico , Sistemas de Liberación de Medicamentos , Metotrexato/análogos & derivados , Fenilalanina/análogos & derivados , Profármacos/uso terapéutico , Neoplasias de la Próstata/tratamiento farmacológico , Proteínas Recombinantes de Fusión/uso terapéutico , Animales , Anticuerpos Antineoplásicos/administración & dosificación , Anticuerpos Antineoplásicos/farmacología , Anticuerpos Antineoplásicos/uso terapéutico , Carboxipeptidasas A/administración & dosificación , Carboxipeptidasas A/inmunología , Carboxipeptidasas A/farmacología , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Humanos , Región Variable de Inmunoglobulina/administración & dosificación , Región Variable de Inmunoglobulina/farmacología , Región Variable de Inmunoglobulina/uso terapéutico , Masculino , Metotrexato/administración & dosificación , Metotrexato/inmunología , Metotrexato/farmacología , Metotrexato/uso terapéutico , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Trasplante de Neoplasias , Células Madre Neoplásicas , Fenilalanina/administración & dosificación , Fenilalanina/inmunología , Fenilalanina/farmacología , Fenilalanina/uso terapéutico , Profármacos/administración & dosificación , Profármacos/farmacología , Antígeno Prostático Específico/inmunología , Neoplasias de la Próstata/inmunología , Neoplasias de la Próstata/patología , Proteínas Recombinantes de Fusión/administración & dosificación , Proteínas Recombinantes de Fusión/farmacología , Trasplante HeterólogoRESUMEN
Using microarray analyses, we identified carboxypeptidase A (MF-CPA), which was induced during pupal ecdysis in the wing discs of Bombyx mori. Here, we report the functional characterization of MF-CPA. MF-CPA has amino acid sequence similarities with the proteins in the carboxypeptidase A/B subfamily, from human to nematode. The MF-CPA gene is expressed during the molting periods in the epithelial tissues. MF-CPA is detected in the molting fluid, which fills the space between the old and new cuticle during molting. By Western blot analysis, we show that MF-CPA is secreted as a zymogen and processed in the molting fluid. Recombinant MF-CPA expressed in the insect cells has carboxypeptidase A activity. We propose that MF-CPA degrades the proteins from the old cuticle during the molting periods and contributes to recycling of the amino acids.
Asunto(s)
Bombyx/enzimología , Bombyx/crecimiento & desarrollo , Carboxipeptidasas A/metabolismo , Regulación del Desarrollo de la Expresión Génica , Muda/fisiología , Secuencia de Aminoácidos , Animales , Baculoviridae , Bombyx/genética , Carboxipeptidasas A/genética , Carboxipeptidasas A/inmunología , Cromatografía Líquida de Alta Presión , Larva/enzimología , Datos de Secuencia Molecular , Filogenia , Conejos , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de AminoácidoRESUMEN
Six basic proteins of 26 to 38 kDa with isoelectric points (pI) > or = 8.5 were abundant in proteins separated by two-dimensional SDS-PAGE from adult rat peritoneal mast cells (MC). One was identified previously as rat mast cell proteinase (RMCP) 1, a chymase of 26 to 28 kDa, pI > 9.0. Microsequence analyses showed that two polypeptides of about 29 and 30 kDa had NH2 terminal amino acid sequences homologous to mouse MC proteinase 5 (MCP-5), whereas the amino terminals of the 33, 35, and 36 kDa proteins were homologous to MC carboxypeptidase A (MC-CPA). Rabbit Abs produced against synthetic peptides of the identified NH2 terminal sequences were used in immunoblot studies. At least three proteins reacted with Abs to MC-CPA, whereas Abs to MCP-5 detected three adjacent polypeptides, rather than just the two identified by using microsequence analysis. Removal of oligosaccharide side chains using peptide:N-glycosidase F reduced the heterogeneity of each set of three polypeptides (MCP-5 and MC-CPA) to a band of each protein of a lower M(r). The serine proteinase inhibitor [3H]diisopropylfluorophosphate ([3H]DFP) bound to a proteinase of 30 to 35 kDa, which is probably MC tryptase (pI < or = 6.0). Immunoblot analysis of proteins from intestinal mucosal mast cells showed RMCP-2, but not RMCP-1, MCP-5, or MC-CPA. This is the first report of MCP-5 in the rat and of clearly distinguishable glycosylated forms of MC CPA. These proteinases appear to be restricted in their distribution to selected MC populations, but little is known about their functions.